The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(naphthalen-2-ylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid ID: ALA5287614
Max Phase: Preclinical
Molecular Formula: C23H15N3O2
Molecular Weight: 365.39
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc2c(c1)nc(Nc1ccc3ccccc3c1)c1ccncc12
Standard InChI: InChI=1S/C23H15N3O2/c27-23(28)16-6-8-18-20-13-24-10-9-19(20)22(26-21(18)12-16)25-17-7-5-14-3-1-2-4-15(14)11-17/h1-13H,(H,25,26)(H,27,28)
Standard InChI Key: RDMBYNWOAJKXAP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
3.2051 -0.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4832 -0.6637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4630 -1.4876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1712 -1.9106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8936 -1.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9105 -0.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7769 -0.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7929 0.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5148 0.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2225 0.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0886 1.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3721 0.6107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3380 1.0350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0645 0.6356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0859 -0.1968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3729 -0.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3535 -0.2202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0645 -0.6450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0491 -1.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3249 -1.8742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3875 -1.4486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8002 -0.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5099 -0.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4899 0.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7688 1.0563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1942 1.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9105 0.6958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1733 1.9106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
2 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
16 15 1 0
16 17 2 0
17 12 1 0
17 18 1 0
19 18 2 0
20 19 1 0
16 21 1 0
21 20 2 0
22 15 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 14 1 0
24 26 1 0
26 27 2 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.39Molecular Weight (Monoisotopic): 365.1164AlogP: 5.38#Rotatable Bonds: 3Polar Surface Area: 75.11Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.02CX Basic pKa: 4.61CX LogP: 3.68CX LogD: 1.32Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -0.84
References 1. Davis-Gilbert ZW, Krämer A, Dunford JE, Howell S, Senbabaoglu F, Wells CI, Bashore FM, Havener TM, Smith JL, Hossain MA, Oppermann U, Drewry DH, Axtman AD.. (2023) Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2., 14 (4): [PMID:37077385 ] [10.1021/acsmedchemlett.2c00530 ]